Lipocine (LPCN) Earnings Date & Reports

Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

LPCN is expected to report earnings to rise 962.50% to -42 cents per share on August 09

Q2'23

Est.

$-0.43

Q1'23

Missed

by $0.01

Q4'22

Missed

by $0.31

Q3'22

Missed

by $0.48

Q2'22

Missed

by $0.64

The last earnings report on May 11 showed earnings per share of -3 cents, missing the estimate of -2 cents. With 19.29K shares outstanding, the current market capitalization sits at 17.01M.

View a ticker or compare two or three

Compare

LPCN